These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 21612462

  • 1. Eculizumab in severe Shiga-toxin-associated HUS.
    Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F.
    N Engl J Med; 2011 Jun 30; 364(26):2561-3. PubMed ID: 21612462
    [No Abstract] [Full Text] [Related]

  • 2. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U, Matar RB, Rotz SJ.
    Pediatr Blood Cancer; 2019 Nov 30; 66(11):e27913. PubMed ID: 31286658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review.
    de Zwart PL, Mueller TF, Spartà G, Luyckx VA.
    Pediatr Nephrol; 2024 May 30; 39(5):1369-1385. PubMed ID: 38057431
    [Abstract] [Full Text] [Related]

  • 9. Treatment of typical (enteropathic) hemolytic uremic syndrome.
    Bitzan M, Schaefer F, Reymond D.
    Semin Thromb Hemost; 2010 Sep 30; 36(6):594-610. PubMed ID: 20865636
    [Abstract] [Full Text] [Related]

  • 10. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
    Walsh PR, Johnson S.
    Pediatr Nephrol; 2019 Sep 30; 34(9):1485-1492. PubMed ID: 30058046
    [Abstract] [Full Text] [Related]

  • 11. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C, Goldstein J, Silberstein C, Zotta E, Belardo M, Repetto HA.
    Arch Argent Pediatr; 2008 Oct 30; 106(5):435-42. PubMed ID: 19030644
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C, Zaloszyc A, Licht C, Pichault V, Frémeaux-Bacchi V, Fischbach M.
    Pediatr Nephrol; 2016 Jan 30; 31(1):157-61. PubMed ID: 26399238
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
    Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M.
    Pediatr Nephrol; 2019 Mar 30; 34(3):517-527. PubMed ID: 30362078
    [Abstract] [Full Text] [Related]

  • 18. Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.
    Percheron L, Gramada R, Tellier S, Salomon R, Harambat J, Llanas B, Fila M, Allain-Launay E, Lapeyraque AL, Leroy V, Adra AL, Bérard E, Bourdat-Michel G, Chehade H, Eckart P, Merieau E, Piètrement C, Sellier-Leclerc AL, Frémeaux-Bacchi V, Dimeglio C, Garnier A.
    Pediatr Nephrol; 2018 Aug 30; 33(8):1385-1394. PubMed ID: 29572749
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.